Stay updated on Tislelizumab Combo in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Tislelizumab Combo in NSCLC Clinical Trial page.

Latest updates to the Tislelizumab Combo in NSCLC Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe latest version adds Contacts/Locations and Study Status (v3.4.2). A government funding notice banner was removed (v3.4.1).SummaryDifference0.9%

- Check21 days agoChange DetectedAdded a government funding notice regarding updates and the NIH Clinical Center status, and updated the page revision to v3.4.1; the previous revision v3.4.0 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check28 days agoChange DetectedThe history view introduces UI enhancements such as a glossary toggle, color-coded additions and deletions in the diff view, and a new revision note (v3.4.0) dated 2026-01-26.SummaryDifference1%

- Check42 days agoChange DetectedThe history now shows that Revision: v3.3.4 was added and Revision: v3.3.3 was removed, indicating a minor site version update that does not affect study data or content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check64 days agoChange DetectedThe page history shows a new revision entry 'Revision: v3.3.3' added and 'Revision: v3.3.2' removed, along with the HHS Vulnerability Disclosure link in the footer; these are minor footer/policy changes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check71 days agoChange DetectedSponsor/organization name updated: 'BeOne Medicines (BeiGene)' was added and the former 'BeiGene' entry removed. This update appears in version 29 with dates around December 2025 (2025-12-10 to 2025-12-15).SummaryDifference0.4%

Stay in the know with updates to Tislelizumab Combo in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tislelizumab Combo in NSCLC Clinical Trial page.